Andrew Bryan - Concepedia

Author

Andrew Bryan

University of Washington ORCID

Also Known As

A Bryan, A. Bryan, Alessandra C. Bryan, Andrew B Bryan, Andrew B. Bryan, Andrew Bryan, Aubrey Bryan, Bryan A., V Vyas

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

University of Washington Fred Hutch Cancer Center University of Michigan University of Washington Medical Center Seattle Cancer Care Alliance

About

Andrew Bryan is an author at University of Washington specializing in medicine, covid-19, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	1.5K
2	Public Health	4	4	724
3	Health Sciences	3	3	290
4	Engineering	2	2	41
5	Natural Sciences	1	1	24

Andrew Bryan

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho Andrew Bryan, Gregory Pepper, Mark H. Wener, Journal of Clinical Microbiology Viral DiagnosticsImmunodeficienciesCovid-19 EpidemiologyUnited StatesCovid-19	2020	594
Frequency and Distribution of Tetracycline Resistance Genes in Genetically Diverse, Nonselected, and Nonclinical <i>Escherichia coli</i> Strains Isolated from Diverse Human and Animal Sources Andrew Bryan, Nir Shapir, Michael J. Sadowsky Applied and Environmental Microbiology Pathogen DetectionGeneticsPathologyAntibiotic ResistanceBacterial Pathogens	2004	254
Inhibition of Host Vacuolar H+-ATPase Activity by a Legionella pneumophila Effector Li Xu, Xihui Shen, Andrew Bryan, PLoS Pathogens Organelle AcidificationProtein SecretionBiochemistryMicrobial PathogensMedicine	2010	227
Clinical Impact of a Multiplex Gastrointestinal Polymerase Chain Reaction Panel in Patients With Acute Gastroenteritis Robert J. Cybulski, Allen Bateman, Lori Bourassa, Clinical Infectious Diseases	2018	136
Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19) Luisa Angelica Lerma, Anu Chaudhary, Andrew Bryan, Journal of Translational Autoimmunity	2020	88
Regulation of Type 1 Fimbriae by Unlinked FimB- and FimE-Like Recombinases in Uropathogenic <i>Escherichia coli</i> Strain CFT073 Andrew Bryan, P. Roesch, Lindsay M. Davis, Infection and Immunity Off StateGeneticsBacteriologyUnlinked Fimb-Molecular Biology	2006	84
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, Journal of Clinical Investigation	2020	84
Prevalence of Coronavirus Disease 2019 Infection and Outcomes Among Symptomatic Healthcare Workers in Seattle, Washington Nandita S Mani, Jehan Z Budak, Kristine F Lan, Clinical Infectious Diseases	2020	71
Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing Immunity Benjamin T. Bradley, Andrew Bryan, Susan L. Fink, Journal of Clinical Microbiology	2021	61
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence Testing in Idaho Andrew Bryan, Gregory Pepper, Mark H. Wener, Viral DiagnosticsCovid-19 EpidemiologyBackground Coronavirus Disease-19Covid-19Diagnostic Test	2020	50

Page 1